Senior Research Scientist, Analytical R&D, Pfizer Inc.
President and Founder
Head Business Development and Partnership, Genethon
President and CEO, AlphaNet, Inc.
Department Chairman, Department of Urology, UT MD Anderson Cancer Center
CEO and Founder, REACH Market Research
Chief Operating Officer, Emendo Biotherapeutics
Chief Executive Officer, Houston Gene Therapeutics
Senior Staff Scientist, T Cell Therapeutics Research Laboratory, City of Hope National Medical Center
Chief Scientific Officer & Co-Founder, AXONIS Therapeutics
Medical Advisory Board Member
CTO, Neurophth Therapeutics
Senior Scientific Advisor, Gene Therapy, WCG
Partner, RWE and Access Consulting, Clarivate
Senior Director of Technology, Gene Therapy, Repligen Corporation
President & CEO, Cornerstone Pharmaceuticals
Associate, Wolf, Greenfield & Sacks, P.C.
DOMHNALL MC GOWAN
Head of Scientific Operations, Boston Labs
Sr. Research Associate II, Analytical Development, Oxford Biomedica Solutions, LLC
SVP, Head of Regulatory Affairs, R&D Quality, IPSEN
Associate Director, C&M International LLC
Associate Director, Global Business Intelligence & Commercial Operations, Apellis Pharmaceuticals
President and CEO, Decibel Therapeutics
JONI L. RUTTER
Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH)
Vice President, Business Development and Alliances, Prescient Therapeutics
RAJESH B. SHUKLA
Senior Medical Director
Non-clinical Manager, Cell and Gene Therapy Catapult
Chief, Division of Cellular and Molecular Therapy, University of Florida
Chief Scientific Officer
Kriya Therapeutics, Inc.
Global Vice President, Cell and Gene Therapy Strategy Lead, PPD
Vice President of Gene Therapy Research, Tenaya Therapeutics
Gene therapy has rapidly moved from theory to practical interventions in clinical disease. This is the conference that brings together those doing the biotechnology firms, the regulators, and the patients into a single, practical, cutting edge conference.
- Michael Fossel